HRS-6719

· Shandong Suncadia Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-6719, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]